Purple Biotech Ltd (PPBT)

$0.68

+0.08

(+13.33%)

Market is closed - opens 7 PM, 23 May 2024

Insights on Purple Biotech Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 127.9%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 232.5% return, outperforming this stock by 319.8%

Performance

  • $0.58
    $0.70
    $0.68
    downward going graph

    14.56%

    Downside

    Day's Volatility :16.99%

    Upside

    2.84%

    downward going graph
  • $0.30
    $1.98
    $0.68
    downward going graph

    55.54%

    Downside

    52 Weeks Volatility :84.73%

    Upside

    65.66%

    downward going graph

Returns

PeriodPurple Biotech LtdIndex (Russel 2000)
3 Months
-15.49%
0.0%
6 Months
-41.18%
0.0%
1 Year
-69.39%
0.0%
3 Years
-87.15%
-20.1%

Highlights

Market Capitalization
14.7M
Book Value
$0.14
Earnings Per Share (EPS)
-0.9
Wall Street Target Price
9.67
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-28.14%
Return On Equity TTM
-49.09%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-120.0K
EBITDA
-22.2M
Diluted Eps TTM
-0.9
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.92
EPS Estimate Next Year
-0.63
EPS Estimate Current Quarter
-0.2
EPS Estimate Next Quarter
-0.19

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 1322.06%

Current $0.68
Target $9.67

Technicals Summary

Sell

Neutral

Buy

Purple Biotech Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Purple Biotech Ltd
Purple Biotech Ltd
32.33%
-41.18%
-69.39%
-87.15%
-85.74%
Moderna, Inc.
Moderna, Inc.
37.56%
83.82%
13.37%
-12.47%
553.14%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
10.42%
24.29%
32.26%
98.6%
210.52%
Novo Nordisk A/s
Novo Nordisk A/s
7.9%
30.89%
58.53%
230.87%
458.51%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
10.52%
25.13%
30.01%
109.26%
156.43%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Purple Biotech Ltd
Purple Biotech Ltd
NA
NA
NA
-0.92
-0.49
-0.28
NA
0.14
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.46
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.16
29.16
1.46
44.2
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.83
45.83
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
28.9
28.9
0.53
17.11
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Purple Biotech Ltd
Purple Biotech Ltd
NA
$14.7M
-85.74%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.0B
553.14%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.8B
210.52%
29.16
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$592.1B
458.51%
45.83
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$115.1B
156.43%
28.9
39.46%

Institutional Holdings

  • Armistice Capital, LLC

    7.21%
  • Wuxi AppTec Co Ltd

    0.74%
  • Kingswood Wealth Advisors LLC

    0.67%
  • Morgan Stanley - Brokerage Accounts

    0.33%
  • Millennium Management LLC

    0.08%
  • Venture Visionary Partners LLC

    0.06%

Company Information

kitov pharmaceuticals ltd. is a financial services company located in israel.

Organization
Purple Biotech Ltd
Employees
20
CEO
Mr. Gil Efron CPA, M.A.
Industry
Miscellaneous

FAQs